Company Search:
Advanced Search
Sponsored Links
Aeglea Bio Therapeutics Inc Company Snapshot
Aeglea Bio Therapeutics Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aeglea Bio Therapeutics Inc with three other companies in this sector in the United States: Can Fite Biopharma Ltd (2018 sales of $3.82 million ), American Bio Medica Corporation ($3.87 million ), and Procyon Corporation ($4.02 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Aeglea Bio Therapeutics Inc
  Stock Performance Chart for Aeglea Bio Therapeutics Inc
  Stock Data: Recent Stock Performance:
  Current Price (11/15/2019): 7.83
(Figures in U.S. Dollars)
1 Week -1.3%   13 Weeks 0.1%  
4 Weeks -0.9%   52 Weeks -5.8%  
Aeglea Bio Therapeutics Inc Key Data:
  Ticker: AGLE Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 3,888,000
(Year Ending Jan 2019).
Employees: 61
  Currency: U.S. Dollars Market Cap: 226,468,977
  Fiscal Yr Ends: December Shares Outstanding: 28,923,241
  Share Type: Common Closely Held Shares: 2,372,463
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.